1. D'Onofrio, Gianluca, Cuccurullo, Claudia, Larsen, Silje Kathrine, Arnesen, Thomas, Bilo, Leonilda. 2023. Novel biallelic variants expand the phenotype of NAA20-related syndrome. In Clinical genetics, 104, 371-376. doi:10.1111/cge.14359. https://pubmed.ncbi.nlm.nih.gov/37191084/
2. Jung, Taek-Yeol, Ryu, Jae-Eun, Jang, Mi-Mi, Ju, Bong-Gun, Kim, Hyun-Seok. 2020. Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis. In Experimental & molecular medicine, 52, 1831-1844. doi:10.1038/s12276-020-00525-3. https://pubmed.ncbi.nlm.nih.gov/33219302/
3. Huber, Monika, Bienvenut, Willy V, Linster, Eric, Hell, Ruediger, Wirtz, Markus. 2019. NatB-Mediated N-Terminal Acetylation Affects Growth and Biotic Stress Responses. In Plant physiology, 182, 792-806. doi:10.1104/pp.19.00792. https://pubmed.ncbi.nlm.nih.gov/31744933/
4. Lasa, Marta, Neri, Leire, Carte, Beatriz, Aragón, Tomás, Aldabe, Rafael. 2020. Maturation of NAA20 Aminoterminal End Is Essential to Assemble NatB N-Terminal Acetyltransferase Complex. In Journal of molecular biology, 432, 5889-5901. doi:10.1016/j.jmb.2020.09.010. https://pubmed.ncbi.nlm.nih.gov/32976911/
5. Santhosh Kumar, Saranya, Naseri, Nima N, Pather, Sarshan R, Rhoades, Elizabeth, Shalem, Ophir. 2024. Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. In Science advances, 10, eadj4767. doi:10.1126/sciadv.adj4767. https://pubmed.ncbi.nlm.nih.gov/38335281/
智鼠故事 
